Free Trial

Rafael Holdings, Inc. (NYSE:RFL) Short Interest Down 67.8% in August

Rafael logo with Medical background

Key Points

  • Rafael Holdings, Inc. saw a significant decrease in short interest, dropping by 67.8% in August, which equates to 62,500 shares as of August 15th.
  • The company was upgraded from a "sell" rating to a "hold" rating by Wall Street Zen on August 10th, reflecting a change in analyst sentiment.
  • CEO Howard S. Jonas made a major purchase of 13,080,457 shares at $1.28 each, indicating significant insider confidence in the company's future.
  • Five stocks to consider instead of Rafael.

Rafael Holdings, Inc. (NYSE:RFL - Get Free Report) was the target of a large decline in short interest in the month of August. As of August 15th, there was short interest totaling 62,500 shares, adeclineof67.8% from the July 31st total of 194,200 shares. Based on an average daily volume of 233,500 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 233,500 shares, the days-to-cover ratio is presently 0.3 days.

Rafael Stock Performance

Shares of RFL stock remained flat at $1.45 during trading hours on Friday. The stock had a trading volume of 78,215 shares, compared to its average volume of 81,435. Rafael has a 12-month low of $1.28 and a 12-month high of $3.19. The stock has a market cap of $50.88 million, a P/E ratio of -1.54 and a beta of 0.89. The stock's 50-day moving average price is $1.78 and its 200-day moving average price is $1.74.

Rafael (NYSE:RFL - Get Free Report) last posted its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) earnings per share for the quarter. Rafael had a negative net margin of 3,127.60% and a negative return on equity of 24.75%. The company had revenue of $0.36 million for the quarter.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut Rafael from a "hold" rating to a "sell" rating in a research report on Friday.

Get Our Latest Analysis on RFL

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Wealth Enhancement Advisory Services LLC purchased a new position in Rafael in the 1st quarter worth approximately $26,000. Simplex Trading LLC purchased a new position in Rafael in the 2nd quarter worth approximately $32,000. Marshall Wace LLP purchased a new position in Rafael in the 2nd quarter worth approximately $50,000. Americana Partners LLC purchased a new position in Rafael in the 2nd quarter worth approximately $76,000. Finally, Cable Car Capital LP purchased a new position in Rafael in the 2nd quarter worth approximately $173,000. 11.30% of the stock is owned by hedge funds and other institutional investors.

Rafael Company Profile

(Get Free Report)

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Featured Articles

Should You Invest $1,000 in Rafael Right Now?

Before you consider Rafael, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rafael wasn't on the list.

While Rafael currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.